杨超,王珊,李长春,等.卵巢恶性生殖细胞瘤患儿62例治疗结果分析[J].第三军医大学学报,2012,34(18):1877. Yang Chao,Wang Shan,Li Changchun,et al.Outcome of children with malignant ovarian germ cell tumor: a report of 62 cases[J].J Third Mil Med Univ,2012,34(21):1877. [2]朱宁生,张婧,曾晓华,等.BMP-4基因影响乳腺癌细胞增殖、凋亡和迁移能力涉及NF-κB途径[J].第三军医大学学报,2012,34(18):1910. [3]杨洁芳,何雄伟.回生口服液对卵巢上皮癌患者化疗毒副反应的影响[J].第三军医大学学报,2015,37(19 ):2000. [4]斯晓燕,张力.西妥昔单抗联合化疗一线治疗非小细胞肺癌20例临床观察[J].第三军医大学学报,2012,34(20):2063. Si Xiaoyan,Zhang Li.Outcomes of cetuximab combined with chemotherapy as first line therapy in 20 patients with non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(21):2063. [5]罗虎,罗丹,宫亮,等.联合CIK细胞与化疗对比单纯化疗治疗中晚期非小细胞肺癌的Meta分析[J].第三军医大学学报,2012,34(20):2119. [6]徐灵莉,邓本敏,唐玲,等.护理风险管理能有效提高糖尿病合并恶性肿瘤患者的化疗疗效[J].第三军医大学学报,2013,35(04):351. Xu Lingli,Deng Benmin,Tang Ling,et al.Risk management of nursing improves chemotherapy efficiency for diabetic patients with malignant tumor[J].J Third Mil Med Univ,2013,35(21):351. [7]卢先锋,戴楠,杨宇馨,等.血清uPAR的水平与小细胞肺癌化疗疗效及预后的关系[J].第三军医大学学报,2012,34(22):2318. Lu Xianfeng,Dai Nan,Yang Yuxin,et al.Serum uPAR and its relationship with chemosensitivity and prognosis in patients with small cell lung cancer[J].J Third Mil Med Univ,2012,34(21):2318. [8]董华琼,刘发兰,田婕丽,等.回生口服液联合多西紫杉醇同期放化疗治疗60例食管癌临床分析[J].第三军医大学学报,2012,34(24):2473. [9]张毅,周艳,郭美琴,等.全乳大切片观察新辅助化疗后乳腺癌浸润性生长特征变化[J].第三军医大学学报,2007,29(21):2083. ZHANG Yi,ZHOU Yan,GUO Mei-qin,et al.Infiltrating characteristics of breast cancer after neoadjuvant chemotherapy: whole breast serial subsection observation[J].J Third Mil Med Univ,2007,29(21):2083. [10]陈显春,杨英,宋爽,等.乳腺癌病友联谊会对提高乳腺癌患者生活质量的作用[J].第三军医大学学报,2007,29(20):1967. [11]邓莉,张轩珍,王卫东,等.重组人内皮抑素联合紫杉醇+顺铂化疗方案治疗人乳腺癌？鼠移植瘤的研究[J].第三军医大学学报,2008,30(09):783. DENG Li,ZHANG Xuan-zhen,WANG Wei-dong,et al.Recombinant human endostatin combined with paclitaxel-cisplatin chemotherapy in treatment of human breast cancer xenograft in nude mice[J].J Third Mil Med Univ,2008,30(21):783. [12]刘亚华,钟唯一,努尔波拉提.乳腺癌患者术前化疗对罗库溴铵肌松效应的影响[J].第三军医大学学报,2009,31(11):1116.
